# Candel Therapeutics, Inc.: Form 8-K, filed Feb 25, 2025

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: 8-K
- Filed: 2025-02-25
- Accepted by EDGAR: Feb 25, 2025, 13:15 ET
- Period: 2025-02-25
- Accession: 0000950170-25-026100
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000095017025026100/cadl-20250225.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000095017025026100/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000095017025026100/cadl-20250225.htm

Filed Feb 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-026100. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.